Australia markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
26.69+0.76 (+2.93%)
At close: 04:00PM EDT
26.84 +0.15 (+0.56%)
After hours: 08:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
897,810
1,072,054
1,598,577
1,526,087
934,842
Cost of revenue
241,058
296,204
458,163
398,490
237,027
Gross profit
656,752
775,850
1,140,414
1,127,597
697,815
Operating expenses
Selling general and administrative
575,921
649,448
955,608
911,356
563,656
Total operating expenses
575,921
649,448
955,608
911,356
563,656
Operating income or loss
80,831
126,402
184,806
216,241
134,159
Interest expense
-
-
701
-
-
Total other income/expenses net
2,328
-95
-46
119
-140
Income before tax
87,053
128,797
184,059
216,129
134,265
Income tax expense
19,290
29,382
40,491
52,098
31,406
Income from continuing operations
67,763
99,415
143,568
164,031
102,859
Net income
67,763
99,415
143,568
164,031
102,859
Net income available to common shareholders
67,763
99,415
143,568
164,031
102,859
Basic EPS
11.03
9.13
12.82
14.01
8.74
Diluted EPS
10.98
9.10
12.73
13.89
8.68
Basic average shares
10,888
10,884
11,195
11,705
11,771
Diluted average shares
10,943
10,921
11,276
11,813
11,850